Table 1.
Robotic-assisted simple prostatectomy (RASP) series in the literature.
| Study | Study Type | Year | Number of Patients | Approach | Prostate Volume (mL) | Operation Time (min) | Conversion to OSP (%) | EBL (mL) | Transfusion Rate (%) | Specimen Weight (g) | Catheher Removal Time (Days) | Length of Stay (Days) | Complications (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sotelo et al. [3] | NC | 2008 | 7 | T | 77.7 | 195 | 0 | 382 | 14.3 | 50.5 | 7.5 | 1.3 | 14 | |
| Yuh et al. [12] | NC | 2008 | 3 | T | 323 | 211 | 0 | 558 | 33 | 301 | NA | 1.3 | 33 | |
| John et al. [13] | NC | 2009 | 13 | E | 100 | 210 | 0 | 500 | 0 | 82 | 6 | 6 | 7.7 | |
| Uffort et al. [14] | NC | 2010 | 15 | T | 70.9 | 128.8 | 0 | 139.3 | 0 | 46.4 | 4.6 | 2.5 | 7 | |
| Sutherland et al. [15] | NC | 2011 | 9 | T | 136.5 | 183 | 11.1 | 206 | 0 | 112 | 13 | 1.3 | 56 | |
| Vora et al. [17] | NC | 2012 | 13 | T | 163 | 179 | 0 | 219 | 0 | 127 | 2.7 | 8.8 | 7.7 | |
| Fareed et al. [18] | NC | 2012 | 8 | E | 130 | 230 | 0 | 425 | 87.5 | 78 | 11 | 4.5 | 37.5 | |
| Matei et al. [19] | NC | 2012 | 35 | T | 96.2 | 186 | 0 | 121 | 0 | 87 | 7.4 | 3.2 | 0 | |
| Coelho et al. [16] | NC | 2012 | 6 | T | 157 | 90 | 0 | 208 | 0 | 145 | 4.8 | 1 | 0 | |
| Dubey et al. [35] | NC | 2012 | 3 | E | NA | 220 | 0 | 160 | NA | NA | 3 | 3.5 | NA | |
| Clavijo et al. [20] | NC | 2013 | 10 | T | 81 | 106 | 0 | 375 | 10 | 81 | 8.9 | 1 | 20 | |
| Banapour et al. [10] | NC | 2014 | 16 | T+E | 141.8 | 228 | 0 | 197 | 0 | 94.2 | 8 | 1.3 | 12.5 | |
| Leslie et al. [21] | NC | 2014 | 25 | T | 149.6 | 214 | 0 | 143 | 4 | 88 | 9 | 4 | 20 | |
| Stolzenburg et al. [24] | NC | 2014 | 10 | E | 143.9 | 122.5 | 0 | 228.8 | 0 | 102 | 7.4 | 8.4 | 10 | |
| Nestler et al. [22] | NC | 2014 | 18 | T | 91 | 193 | 0 | 190 | 5.5 | 91 | 5.3 | NA | 5.5 | |
| Elsamra et al. [23] | NC | 2014 | 15 | T | 156 | 189 | 0 | 290 | 0 | 110 | 8.67 | 2.4 | 14 | |
| Patel et al. [25] | NC | 2014 | 20 | T+E | NA | NA | NA | NA | NA | 134.7 | NA | 1.7 | NA | |
| Nething et al. [26] | NC | 2014 | 7 | T | 144.9 | 204.7 | 0 | 521 | NA | 96.3 | 8.28 | 2.57 | 0 | |
| Autorino et al. [37] | C | 2015 | 487 | T+E | 110 | 154.5 | 3.1 | 200 | 1 | 75 | 7 | 2 | 16.6 | |
| Pokorny et al. [27] | NC | 2015 | 69 | T | 129 | 97 | 0 | 200 | 1.5 | 84 | 3 | 4 | 33 | |
| Hoy et al. [36] | C | 2015 | 4 | T | 238 | 161.3 | 0 | 218.8 | 0 | 123.6 | NA | 2.3 | 0 | |
| Castillo et al. [28] | NC | 2016 | 34 | T | 117 | 96 | 0 | 200 | 5.8 | 76 | 4.6 | 2.2 | 20.5 | |
| Martin Garzon et al. [38] | C | 2016 | 154 | E | 78 | 157 | 0.7 | 455 | 6 | 71 | 9.3 | NA | 12 | |
| Pavan et al. [39] | C | 2016 | 130 | T+E | 118.5 | 150 | 10.8 | 250 | NA | 77 | 5 | 5 | 16.9 | |
| Umari et al. [40] | C | 2017 | 81 | T | 130 | 105 | 0 | 250 | 1.2 | 89 | 3 | 4 | 31 | |
| Zhang et al. [41] | C | 2017 | 32 | E | NA | 274 | NA | NA | 9.4 | 110 | 8 | 2.3 | 3.1 | |
| Sorokin et al. [42] | C | 2017 | 59 | T | 136.9 | 161.4 | 0 | 339 | 3.4 | 82.9 | 5.7 | 1.5 | 19 | |
| Cacciamani et al. [29] | NC | 2018 | 23 | T | 108.1 | 160.6 | 0 | 98.6 | 0 | 63.1 | 7 | 2.1 | 4.3 | |
| Wang et al. [30] | NC | 2018 | 27 | T | 82 | 169 | 0 | 235 | 0 | 47.5 | 1.6 | 3 | 22.2 | |
| Chavali et al. [31] | NC | 2018 | 28 | T | 180 | 180 | 0 | 200 | 0 | 90 | 8 | 2 | 14 | |
| Johnson et al. [33] | NC | 2018 | 120 | T | 121.5 | 157 | 0 | NA | 3.3 | 74 | 4 | 1 | 18.3 | |
| Nestler et al. [44] | C | 2019 | 35 | NA | 94.5 | 182 | 0 | NA | 9.4 | 77 | 5 | 5 | 25 | |
| Mourmouris et al. [43] | C | 2019 | 26 | T | NA | 133.6 | 0 | 274 | 0 | 115 | 3 | 3.4 | 3.8 | |
| Simone et al. [32] | NC | 2019 | 12 | T | 102 | 150 | 0 | 250 | 8 | 78 | 7 | 3 | 30 | |
| Steinberg et al. [34] | NC | 2019 | 10 | E | 104 | 172 | 0 | 141 | 0 | 65 | 1.9 | 1.1 | 0 | |
| Study | Study Type | Preop IPSS | Postop IPSS | Preop QoL | Postop QoL | Preop IIEF/SHIM | Postop IIEF/SHIM | Preop Qmax (mL/sn) | Postop Qmax (mL/sn) | Preop PVR (mL) | Postop PVR (mL) | Postop İncontinence | Bladder neck Contracture (n) | Follow up (Months) |
| Sotelo et al. [3] | NC | 22 | 1.7 | 3.8 | 2.3 | NA | NA | 17.7 | 55.5 | NA | NA | NA | N/A | 0 |
| Yuh et al. [12] | NC | 17.7 | NA | 4.1 | NA | NA | NA | NA | NA | NA | NA | 0 | 1 | NA |
| John et al. [13] | NC | NA | NA | NA | NA | NA | NA | NA | 23 | 85 | 0 | NA | 1 | 13 |
| Uffort et al. [14] | NC | 23.9 | 1.8 | 4.9 | 2.2 | NA | NA | NA | NA | 265.8 | 44.2 | NA | N/A | 3 |
| Sutherland et al. [15] | NC | 17.8 | 7.8 | NA | NA | 12.7 (SHIM) | 12.5 (SHIM) | NA | NA | 214 | 18.2 | 1 | N/A | 9 |
| Vora et al. [17] | NC | 18.2 | 5.3 | NA | NA | NA | NA | 4.4 | 19.1 | 207.3 | 12.7 | 0 | N/A | 7.2 |
| Fareed et al. [18] | NC | 19.5 | 3 | NA | NA | NA | NA | 5.2 | 18 | 60 | 37 | 0 | N/A | 1 |
| Matei et al. [19] | NC | 28 | 7 | NA | NA | NA | NA | 6.6 | 18.9 | NA | NA | NA | N/A | 0 |
| Coelho et al. [16] | NC | 19.8 | 5.5 | NA | NA | NA | NA | 7.7 | 19 | NA | NA | 0 | N/A | 2 |
| Dubey et al. [35] | NC | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | N/A | NA |
| Clavijo et al. [20] | NC | 18.8 | 1.7 | 3.7 | 0.5 | NA | NA | 12.4 | 33.5 | NA | NA | 0 | N/A | 1 |
| Banapour et al. [10] | NC | 22 | 7 | 4 | 2 | NA | NA | NA | NA | 194 | 56 | 0 | N/A | 0 |
| Leslie et al. [21] | NC | 23.9 | 3.6 | NA | NA | 12.8 (SHIM) | NA | 11.3 | 20 | 208.1 | 36.9 | 1 | N/A | 6 |
| Stolzenburg et al. [24] | NC | 21.9 | 3.4 | NA | NA | NA | NA | 9.3 | 20.7 | 121.9 | 57.5 | 0 | N/A | 6 |
| Nestler et al. [22] | NC | 25 | 6.1 | 5 | 1.1 | 59 (IIEF) | 56.8 (IIEF) | 9 | 28.2 | NA | NA | 1 | 0 | 1 |
| Elsamra et al. [23] | NC | 16.2 | 4.5 | NA | NA | NA | NA | NA | NA | 428 | 33 | 3 | N/A | 3 |
| Patel et al. [25] | NC | 14.7 | NA | NA | NA | NA | NA | NA | NA | 414 | NA | NA | N/A | NA |
| Nething et al. [26] | NC | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 0 | N/A | 10 |
| Autorino et al. [37] | C | 23 | 7 | 4 | NA | 15 (SHIM) | 15 (SHIM) | 8 | 25 | 108 | NA | NA | 3 patients | 12 |
| Pokorny et al. [27] | NC | 25 | 3 | NA | NA | NA | NA | 7 | 23 | 73 | 0 | 0 | N/A | 6 |
| Hoy et al. [36] | C | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | N/A | 3 |
| Castillo et al. [28] | NC | 23.5 | 7.1 | NA | NA | NA | NA | 10.4 | 23.1 | NA | NA | 0 | 1 patient | 12 |
| Martin Garzon et al. [38] | C | 22 | 6.5 | 3.8 | 1 | 18.5 (SHIM) | 16 (SHIM) | 11.5 | 33 | NA | NA | 9 | 1 patient developed anterior urethral stricture | 12 |
| Pavan et al. [39] | C | 23 | 5 | 6 | NA | 18 (SHIM) | 17 (SHIM) | 9 | 22 | NA | NA | NA | N/A | 10.3 |
| Umari et al. [40] | C | 25 | 5 | NA | NA | NA | NA | 8 | 23 | 73 | 0 | 1 | 0 | 12 |
| Zhang et al.[41] | C | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | N/A | NA |
| Sorokin et al. [42] | C | 18.8 | 7.3 | 3.9 | 1.3 | NA | NA | 9.8 | 22.4 | 118 | 3.5 | 0 | 0 | 6 |
| Cacciamani et al. [29] | NC | 23.1 | NA | NA | NA | NA | NA | NA | NA | NA | NA | 0 | N/A | 3 |
| Wang et al. [30] | NC | 25 | NA | 6 | NA | 18 (IIEF) | 17.5 (IIEF) | 6 | NA | 85 | NA | 0 | No strictue but 7 patients required closure of small urethrotomies | 16.4 |
| Chavali et al. [31] | NC | 19 | NA | NA | NA | NA | NA | 9 | NA | 120 | NA | NA | N/A | NA |
| Johnson et al. [33] | NC | NA | NA | NA | NA | NA | NA | 8.9 | 18.8 | NA | 9 | 0 | N/A | 3.2 |
| Nestler et al. [44] | C | 23 | NA | 5 | NA | NA | NA | NA | NA | NA | NA | 0 | N/A | 12 |
| Mourmouris et al. [43] | C | 22.9 | 5.7 | NA | NA | NA | NA | 10.1 | 19.1 | 178.5 | 25.5 | NA | N/A | 3 |
| Simone et al. [32] | NC | 33 | 6 | NA | NA | 27 (IIEF) | 27 (IIEF) | 7.7 | 18.6 | 175 | 30 | 0 | N/A | 12 |
| Steinberg et al. [34] | NC | 20.8 | 12.9 | NA | NA | NA | NA | 8.6 | 11.2 | 119 | 40.9 | 1 (transient) | N/A | 28.7 |
EBL, estimated blood loss; IPSS, international prostate symptom score; QoL, quality of life; Qmax, maximum urinary flow rate; PVR, postvoid residual urine; IIEF, international index of erectile function; SHIM, Sexual Health Inventory for Men; NC, non-comparative; C, comparative.